Aviva
MED icon

Aviva’s Medifast MED Stock Holding History

Aviva’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-34,398
Closed -$658K – 883
2024
Q3 		$658K Buy
34,398
+7,045
+26% +$136K ﹤0.01% 736
2024
Q2 		$597K Buy
27,353
+10,697
+64% +$285K ﹤0.01% 790
2024
Q1 		$638K Buy
16,656
+7,564
+83% +$366K ﹤0.01% 802
2023
Q4 		$611K Buy
9,092
+1,769
+24% +$123K ﹤0.01% 834
2023
Q3 		$548K Sell
7,323
-9,499
-56% -$843K ﹤0.01% 872
2023
Q2 		$1.55M Buy
16,822
+3,129
+23% +$279K 0.01% 683
2023
Q1 		$1.42M Buy
13,693
+5,275
+63% +$585K 0.01% 795
2022
Q4 		$971K Sell
8,418
-4,440
-35% -$517K ﹤0.01% 856
2022
Q3 		$1.39M Buy
12,858
+1,430
+13% +$205K 0.01% 862
2022
Q2 		$2.06M Sell
11,428
-1,292
-10% -$231K 0.01% 793
2022
Q1 		$2.17M Buy
12,720
+509
+4% +$96K 0.01% 816
2021
Q4 		$2.56M Buy
12,211
+5,026
+70% +$1.04M 0.01% 784
2021
Q3 		$1.38M Buy
+7,185
New +$1.77M 0.01% 911

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Aviva's MED Position: Q4 2024 in Review

Aviva sold out of Medifast (MED) in Q4 2024, closing a stake of 34,398 shares — an estimated $658K sold.

Aviva first reported a position in MED in Q3 2021 and held it in 13 quarters. The position peaked at $2.56M in Q4 2021. 129 funds tracked by Wall St. Rank hold MED as of Q4 2024.

  • Aviva reported no remaining Medifast position as of Q4 2024 after selling out during the quarter.
  • Aviva sold 34,398 Medifast shares in Q4 2024, an estimated $658K.
  • Aviva first reported a position in Medifast in Q3 2021 and held it in 13 quarters.
  • Aviva's Medifast position peaked at $2.56M in Q4 2021.
  • 129 funds tracked by Wall St. Rank held Medifast as of Q4 2024.

Based on Aviva's 13F filing for Q4 2024, filed 13 Feb 2025.